Sorin Group is pleased to announce the acquisition of CalMed Labs, Inc.

Jul, 24 2012
Sorin Group is pleased to announce the acquisition of CalMed Labs, Inc.
With the recent addition of a minimally invasive cannulae line and now the acquisition of CalMed, Sorin Cardiopulmonary has achieved our goal of becoming a leading supplier of cannulae for cardiac procedures.
 
Why was this goal important?
Quite simply, you told us it was. You wanted a single, high quality resource with a complete line of cardiac cannulae for every patient and every case.
 

The addition of CalMed to the Sorin Cardiopulmonary portfolio shows our commitment to the needs of the cardiopulmonary community, today and long into the future.
To learn more, please contact your Sorin Cardiopulmonary Sales Representative, call +39 02 37027030 or visit  www.sorin.com,